Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The price of Century Therapeutics Inc (NASDAQ: IPSC) closed at $0.56 in the last session, up 8.23% from day before closing price of $0.52. In other words, the price has increased by $8.23 from its previous closing price. On the day, 1.38 million shares were traded.
Ratios:
We take a closer look at IPSC’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 11.70 and its Current Ratio is at 11.70. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.20.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on August 08, 2024, initiated with a Buy rating and assigned the stock a target price of $6.
On August 28, 2023, JP Morgan Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $28 to $5.
On December 27, 2022, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $19.Chardan Capital Markets initiated its Buy rating on December 27, 2022, with a $19 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 16 ’25 when Pfeiffenberger Brent bought 29,552 shares for $0.55 per share.
Farid Adrienne sold 1,024 shares of IPSC for $563 on May 05 ’25. The Chief Operations Officer now owns 250,693 shares after completing the transaction at $0.55 per share. On May 05 ’25, another insider, Carr Douglas, who serves as the SVP Finance & Operations of the company, sold 295 shares for $0.55 each. As a result, the insider received 162 and left with 410,886 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.42 while its Price-to-Book (P/B) ratio in mrq is 0.20.
Stock Price History:
Over the past 52 weeks, IPSC has reached a high of $3.47, while it has fallen to a 52-week low of $0.34. The 50-Day Moving Average of the stock is 6.41%, while the 200-Day Moving Average is calculated to be -49.43%.
Shares Statistics:
A total of 86.15M shares are outstanding, with a floating share count of 40.56M. Insiders hold about 55.05% of the company’s shares, while institutions hold 28.68% stake in the company.
Earnings Estimates
At present, 3.0 analysts are actively evaluating the performance of Century Therapeutics Inc (IPSC) in the stock market.The consensus estimate for the next quarter is -$0.39, with high estimates of -$0.37 and low estimates of -$0.41.
Analysts are recommending an EPS of between -$0.24 and -$0.36 for the fiscal current year, implying an average EPS of -$0.31. EPS for the following year is -$1.68, with 3.0 analysts recommending between -$1.54 and -$1.79.
Revenue Estimates
A total of 3 analysts have provided revenue estimates for IPSC’s current fiscal year. The highest revenue estimate was $109.2M, while the lowest revenue estimate was $109.16M, resulting in an average revenue estimate of $109.19M. In the same quarter a year ago, actual revenue was $6.59M
